biogen idec inc (BIIB:NASDAQ GS)
Spyros Artavanis-Tsakonas Ph.D.
Chief Scientific Officer and Senior Vice President, Biogen Idec Inc.
|Age||Total Calculated Compensation||This person is connected to 11 board members in 2 different organizations across 4 different industries.|
See Board Relationships
Prof. Spyros Artavanis-Tsakonas, Ph.D. has been the Chief Scientific Officer and Senior Vice President of Biogen Idec Inc. since May 2013. Prof. Artavanis-Tsakonas is the Scientific Co-Founder of Exelixis Pharmaceuticals, Inc., Cellzome and Anadys Pharmaceuticals, Inc. He serves as the President of Fondation Santé. Prof. Artavanis-Tsakonas served as Interim Chief Scientific Officer while on sabbatical from Harvard Medical School. He serves as the Chairman of Novartis ...
225 Binney StreetPhone: 617-679-2000
Cambridge, Massachusetts 02142
Board Members Memberships*
President and Director
University of Cambridge
Eidgenössische Technische Hochschule Zürich
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Lamberto Andreotti||Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee|
Bristol-Myers Squibb Company
|Robert J. Hugin MBA||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Lars Rebien Sørensen||Chief Executive Officer and Member of Executive Management|
Novo Nordisk A/S
|Yoshihiko Hatanaka||Chief Executive Officer, President and Representative Director|
Astellas Pharma, Inc.
|¥170.0M||Compensation as of Fiscal Year 2014.|